At a glance: A pharmaceutical-pathway category that requires licensed manufacturing and market authorization. Formula feasibility, active loading, film size and legal status are evaluated before sampling.

Representative Product Concepts

Nicotine 2 mg / 4 mg ODF
Cytisine ODF feasibility

Custom Development Options

Formula & dosage form

Ingredient selection, target loading, film dimensions, dissolution profile and taste-masking approach are developed as one system.

Flavor & dietary positioning

Mint, berry, watermelon, citrus and peach options; sugar-free, vegan, gluten-free and non-GMO positioning can be evaluated.

Primary & retail packaging

Individual foil sachets with 10, 20 or 30 strips per carton, plus printed boxes or tins for private-label programs.

Development Considerations

Oral dissolving film performance depends on more than the headline ingredient. Solubility, particle size, pH, polymer compatibility, residual moisture, flavor interactions and barrier packaging all affect appearance, dose uniformity, mechanical strength and in-mouth experience. A successful project begins with a target product profile and ends with market-specific label and stability review.

Licensed pharmaceutical pathway only. Nicotine and cytisine products may be regulated as medicines. They are not treated as ordinary dietary-supplement private-label products and require suitable licensed facilities, registration and market authorization.

Request a Feasibility Review

Send your target ingredients, per-strip dosage, flavor, pack count, annual forecast and sales market. Our team will review whether the concept is technically and commercially suitable for OEM, private label or custom ODM development.

Discuss This Product

Smoking Cessation ODF Development